Mehmet TECELLİOGLU, A. Cemal OZCAN, Hatice TOSUN

Leber'in herediter optik nöropatisi ve multipl skleroz birlikteliği: olgu sunumu

Leber'in kalıtsal optik nöropatisi (LHON) akut/subakut, ağrısız, santral görme kaybı ile karakterize, mitokondriyal genetik bir hastalıktır. Olguların çoğunda sadece göz tutulumu olur, bazen kardiyak bozukluklar, nörolojik semptomlar, iskelet anormallikleri tabloya eklenir. LHON'lu hastaların beyin ve omurilik MRG'lerinde nadir olmayarak demyelinizan lezyonlar görülebilir, bazen multipl skleroz benzeri klinik tablo ortaya çıkabilir (Harding Sendromu). Bu yazıda, eşzamanlı bilateral görme kaybı yakınması ile başvuran ve mt. DNA gen mutasyonu (mt.DNA 3460G>A) saptanıp LHON tanısı alan, eşlik eden nörolojik belirtileri ve beyin MRG bulguları multipl sklerozu telkin eden erkek olgu sunulmaktadır. Bu olgularda tanı süreçleri ve özellikle MS tedavisi gözden geçirilmektedir.

Multiple sclerosis associated with leber's hereditary optic neuropathy: a case report

Leber's hereditary optic neuropathy (LHON) is a mitochondrial inherited disease characterized by acute/subacute painless central visual loss. Except for optic atrophy, LHON patients are usually otherwise healthy. Occasionally, LHON is associated with neurological, cardiac, and skeletal changes. The same MRI pattern of abnormalities can be found in patients with LHON. It is sometimes associated with clinical signs of multiple sclerosis (Harding Syndrome). In this report, we present the case of a male patient with complaints of bilateral visual loss, who was diagnosed with Leber's hereditary optic neuropathy that was confirmed by the presence of a mutation at 3460G>A position. He was also diagnosed with comorbid multiple sclerosis which was confirmed by clinical findings and MR imaging.

PDF

___

1. Sadun AA, La Morgia C, Carelli V. Leber's hereditary optic neuropathy. Curr Treat Options Neurol. 2011;13(1):109-17.
2. Fraser JA, Biousse V, Newman NJ. The neuroophthalmology of mitochondrial disease. Surv Ophthalmol 2010;55(4):299-334.
3. Perez F, Anne O, Debruxelles S, Menegon P, Lambrecq V, Lacombe D. Leber's optic neuropathy associated with disseminated white matter disease: a case report and review. Clin Neurol Neurosurg 2009;111(1):83-6.
4. Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, Sonninen P. Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995;59(2):160-4.
5. Matthews L, Enzinger C, Fazekas F, Rovira A, Ciccarelli O, Dotti MT. MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis. J Neurol Neurosurg Psychiatry 2014.
6. Palace J. Multiple sclerosis associated with Leber's hereditary optic neuropathy. J Neurol Sci 2009;286(1- 2):24-7.
7. Newman NJ. Treatment of Leber hereditary optic neuropathy. Brain 2011;134(Pt 9):2447-50.
8. Buhmann C, Gbadamosi J, Heesen C. Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapy. Acta Neurol Scand 2002;106(4):236-9.
9. Pfeffer G, Burke A, Yu-Wai-Man P, Compston DA, Chinnery PF. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology 2013;81(24):2073-81.
10. Piotrowska A, Korwin M, Bartnik E, Tonska K. Leber hereditary optic neuropathy - historical report in comparison with the current knowledge. Gene 2015;555(1):41-9.
11. Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 2001;3(3):119-25.
12. Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115(Pt 4):979-89.
13. Bomprezzi R. Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther Adv Neurol Disord 2015;8(1):20-30.